Search Results for keywords:"HIV prevention"

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services (HHS), has renewed the charter for the CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHAC). This renewal extends the committee's charter until November 25, 2026. The committee focuses on providing guidance and recommendations related to the prevention and treatment of these diseases. Jonathan Mermin, M.D., M.P.H., is the designated federal officer for this committee.

The Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) are holding a public meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT) on April 12, 2021. This meeting is open to the public and can be accessed through telephone or web conference, with limited lines available. The Committee will discuss topics like HIV testing guidelines and new methods for HIV and HCV testing. The meeting is intended to advise on preventing and controlling these diseases and supporting healthcare services for affected individuals.

The National Institute on Drug Abuse, part of the National Institutes of Health, announced several closed meetings to discuss and evaluate grant applications. These meetings, scheduled for February 2021, will be held virtually due to the confidential nature of the discussions, which may involve trade secrets and personal information. Committees will review applications related to HIV prevention, gene editing in marmosets, validating genes involved in substance use disorders, and NIDA Centers Review. As these are closed meetings, the public will not be able to attend.

The Centers for Disease Control and Prevention (CDC) is inviting public comments on a proposed information collection project focused on HIV prevention for Latina transgender women who have sex with men. The project, named ChiCAS, aims to evaluate a locally developed intervention designed to promote condom use, pre-exposure prophylaxis (PrEP), and medically supervised hormone therapy. The study will involve a quantitative assessment and interviews to measure participants' HIV risk behaviors and the intervention's effectiveness in improving health outcomes. The CDC is following the requirements of the Paperwork Reduction Act of 1995 to seek feedback and approval for this proposed data collection.